Free tool
Diagnostics stocks
We cover 6 companies grouped under the Diagnostics theme. The median market value in the group is $119.67M. Across the group, the median move over the past trading day is −0.30%. Price change over the past year runs from −47.7% to +93.8% across the middle 80 percent of the group, with a median of −8.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
6 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| YDES | YD Bio Ltd | $331.49M | Small cap | −64.97% |
| XGN | Exagen Inc. | $184.11M | Small cap | −22.84% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| BIAF | bioAffinity Technologies, Inc. | $3.14M | Micro cap | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.